Efficacy of group-based Acceptance and Commitment Therapy in patients with breast cancer
Not Applicable
Completed
- Conditions
- Effect of ACT Group Therapy on Patients with Breast Cancer.F40-F48
- Registration Number
- IRCT20181209041894N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Age between 25 and 60
- People under chemotherapy
- Apart from cancer, there is no physical or psychological illness
- Absence in other courses at least 6 months
Exclusion Criteria
Having other cancers
Inability to attend meetings due to physical illness
A history of acute mental illness with a psychiatrist's opinion
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of people who have a self-differentiating questionnaire score of under 70. Timepoint: At the beginning of the study (before the intervention), the end of the study, two months later. Method of measurement: Dreik-Mordak self-differentiation questionnaire.;The percentage of people who score in the difficulty questionnaire in adjusting their excitement of Gertz and Roemer are over 108. Timepoint: At the beginning of the study (before the intervention), the end of the. Method of measurement: Gritz & Roemer's Thrill Setting Questionnaire.;Percentage of people whose FOP-Q questionnaire score is above 74. Timepoint: At the beginning of the study (before the intervention), the end of the. Method of measurement: , FOP-Q Questionnaire.;The percentage of people with a general health questionnaire score of 28 (GHQ-28) is above 42. Timepoint: At the beginning of the study (before the intervention), the end of the. Method of measurement: General Health Questionnaire (GHQ-28).
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ACT therapy's impact on self-differentiation in breast cancer patients?
How does group-based ACT compare to standard CBT in managing fear of disease progression in breast cancer?
Are there specific biomarkers associated with emotion dysregulation in breast cancer patients undergoing ACT?
What adverse events are commonly reported in ACT group therapy for breast cancer and how are they managed?
What combination therapies show synergistic effects with ACT in improving mental health outcomes for breast cancer patients?